Two Distinct Transcriptional Subtypes of Severe Type 2 Asthma in NSAID ‐Exacerbated Respiratory Disease
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Radosław Kacorzyk, Piotr Szatkowski, Bogdan Jakieła, Adam Ćmiel, Marek Sanak, Lucyna Mastalerz |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Sputum Eosinophil and Macrophage Changes After Aspirin Challenge in Patients With Nonsteroidal Anti‐Inflammatory Drug–Exacerbated Respiratory Disease
by: Gabriela Trąd‐Wójcik, et al.
Published: (2025)
by: Gabriela Trąd‐Wójcik, et al.
Published: (2025)
Unique effect of aspirin on local 15‐oxo‐eicosatetraenoic acid synthesis in asthma patients with aspirin hypersensitivity
by: Piotr Szatkowski, et al.
Published: (2024)
by: Piotr Szatkowski, et al.
Published: (2024)
Effect of Aspirin Challenge on Innate Lymphoid Cells in Asthma Patients With Aspirin Hypersensitivity
by: Radosław Kacorzyk, et al.
Published: (2025)
by: Radosław Kacorzyk, et al.
Published: (2025)
Omics in Nonsteroidal Anti‐Inflammatory Drugs‐Exacerbated Respiratory Disease: Current Evidence From the Upper and Lower Airways
by: Aleksandr iAkushev, et al.
Published: (2025)
by: Aleksandr iAkushev, et al.
Published: (2025)
Systemic N‐Acylethanolamines and Other Lipid Mediators Are Associated With NSAID ‐Exacerbated Respiratory Disease
by: Viljami E. Salmi, et al.
Published: (2025)
by: Viljami E. Salmi, et al.
Published: (2025)
Correspondence: Proposed amendment to the nomenclature of allergic diseases and hypersensitivity reactions: Looking beyond the classic paradigms
by: Lucyna Mastalerz
Published: (2024)
by: Lucyna Mastalerz
Published: (2024)
NLRP1 Is a Prominent Inflammasome Sensor Found in Bronchial Epithelial Cells in Asthma and Can Be Activated by Rhinovirus A16
by: Anet Laanesoo, et al.
Published: (2025)
by: Anet Laanesoo, et al.
Published: (2025)
Incidence of New Asthma and Asthma Exacerbation Pre‐ and Post‐ COVID ‐19 Pandemic in the United States
by: Ryan C. Lee, et al.
Published: (2026)
by: Ryan C. Lee, et al.
Published: (2026)
Enhancing Asthma Pharmacogenetics Through Subtype‐Specific Associations
by: Shraddha Piparia, et al.
Published: (2024)
by: Shraddha Piparia, et al.
Published: (2024)
Distinct Phenotypes of Peripheral Innate Lymphoid Cells and T Cells in Type 2 and Non‐Type 2 Asthma
by: Maura M. Kere, et al.
Published: (2025)
by: Maura M. Kere, et al.
Published: (2025)
Natural History of Nonsteroidal Anti‐Inflammatory Drug‐Exacerbated Respiratory Disease: A Retrospective, Single‐Centre Study
by: María José Peñalver, et al.
Published: (2026)
by: María José Peñalver, et al.
Published: (2026)
Clinical Predictors of Longitudinal Respiratory Exacerbation Outcomes in Young Hospitalised Children
by: Laura A. Coleman, et al.
Published: (2025)
by: Laura A. Coleman, et al.
Published: (2025)
Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction
by: Renaud Louis, et al.
Published: (2025)
by: Renaud Louis, et al.
Published: (2025)
Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two‐Year Real‐World Data With Benralizumab
by: David J. Jackson, et al.
Published: (2024)
by: David J. Jackson, et al.
Published: (2024)
Type 2 gene expression signature in severe asthma associates with more advanced airway remodeling
by: Bogdan Jakiela, et al.
Published: (2025)
by: Bogdan Jakiela, et al.
Published: (2025)
Differential Expression of Type 1 and Type 17 Immune Pathways and Chemokines in Mild‐to‐Severe Asthma With Mid to High Neutrophilic Inflammation
by: Elisa Arrigo, et al.
Published: (2025)
by: Elisa Arrigo, et al.
Published: (2025)
Dual GIPR and GLP ‐ 1R Agonist Tirzepatide Is Associated With Fewer Asthma Exacerbations in Adults With Obesity
by: Syona Mehta, et al.
Published: (2026)
by: Syona Mehta, et al.
Published: (2026)
How Badly Does India Need Biologics for Severe Asthma?
by: Subhabrata Moitra, et al.
Published: (2025)
by: Subhabrata Moitra, et al.
Published: (2025)
Bronchodilator Reversibility of Spirometry and Oscillometry Ratios in Severe Refractory Asthma
by: Robert Greig, et al.
Published: (2025)
by: Robert Greig, et al.
Published: (2025)
Clustering of the Bronchial Epithelial Immune Response to Viral Stimulation in Patients With Asthma Identifies Clinically Recognisable Epithelial Exacerbation Response Profiles
by: Laurits Frøssing, et al.
Published: (2025)
by: Laurits Frøssing, et al.
Published: (2025)
Sensitisation to Staphylococcus Aureus Enterotoxin; a Driver of Airway Inflammation in Severe Asthma?
by: Freja Friis Lajer, et al.
Published: (2025)
by: Freja Friis Lajer, et al.
Published: (2025)
Evaluation of Small Airways Dysfunction With Dupilumab Using Airway Oscillometry in Uncontrolled Severe Asthma
by: Kirsten E. Stewart, et al.
Published: (2025)
by: Kirsten E. Stewart, et al.
Published: (2025)
Mechanisms and Treatment of Type 2 High and Low Asthma Endotypes
by: Timothy C. Chin‐See‐Chong, et al.
Published: (2025)
by: Timothy C. Chin‐See‐Chong, et al.
Published: (2025)
Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma
by: Hazel Marriott, et al.
Published: (2026)
by: Hazel Marriott, et al.
Published: (2026)
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super‐Response and Remission With Mepolizumab
by: Danilo Di Bona, et al.
Published: (2024)
by: Danilo Di Bona, et al.
Published: (2024)
Airway Basal Stem Cell Population Is Enlarged in Bronchial Thermoplasty Treated Airways in Severe Asthma Patients
by: Tessa E. Gillett, et al.
Published: (2025)
by: Tessa E. Gillett, et al.
Published: (2025)
Tezepelumab Improves Small Airways Dysfunction in Severe Asthma: A 52‐Week Real‐World Study
by: Francesco Menzella, et al.
Published: (2026)
by: Francesco Menzella, et al.
Published: (2026)
A Real‐World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma
by: Dennis Thomas, et al.
Published: (2026)
by: Dennis Thomas, et al.
Published: (2026)
Asthma and Atopic Dermatitis in Asia, 1990–2021: The Global Burden of Disease Study 2021
Published: (2025)
Published: (2025)
Biologic Prescription Patterns and Biomarker Determinants of First‐Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis
by: Marianne Baastrup Soendergaard, et al.
Published: (2025)
by: Marianne Baastrup Soendergaard, et al.
Published: (2025)
Mass Spectrometry‐Based Proteomics Analysis of Nasal Fluid Uncovers Differentially Expressed Proteins as Potential Biomarkers of Allergic Asthma
by: Jamie A. Rosado Alicea, et al.
Published: (2025)
by: Jamie A. Rosado Alicea, et al.
Published: (2025)
Digital Innovation in Asthma Management in Italy: Results From the “Confronting Asthma Survey”
by: Manuela Latorre, et al.
Published: (2025)
by: Manuela Latorre, et al.
Published: (2025)
Variants in Genes Encoding Innate Lymphoid Cells Type 2 Surface Markers Affecting Asthma and Atopy Pathologies
by: Raphael Chagas Silva, et al.
Published: (2026)
by: Raphael Chagas Silva, et al.
Published: (2026)
Unsupervised Machine Learning Identifies Asthma Phenotypes in the Population‐Based West Sweden Asthma Study
by: Muwada Bashir Awad Bashir, et al.
Published: (2025)
by: Muwada Bashir Awad Bashir, et al.
Published: (2025)
Asthma With Fixed Obstruction Displays a Similar Small Airway Dysfunction to That Observed in Asthma– COPD Overlap
by: Toshihiro Shirai, et al.
Published: (2025)
by: Toshihiro Shirai, et al.
Published: (2025)
Allergen Immunotherapy for the Prevention and Treatment of Asthma
by: Thierry Batard, et al.
Published: (2024)
by: Thierry Batard, et al.
Published: (2024)
Association Between Asthma Biologics and Risk of Herpes Zoster Among US Adults With Asthma: A Pairwise Comparison
by: Chun‐Tse Hung, et al.
Published: (2026)
by: Chun‐Tse Hung, et al.
Published: (2026)
Food Sensitization Is Associated With Atopic Dermatitis Severity, Gut‐Derived Metabolites and Leaky Gut in Adults
by: Leszek Blicharz, et al.
Published: (2025)
by: Leszek Blicharz, et al.
Published: (2025)
Mapping the Burden and Risk Factors of Allergic Diseases and Asthma Among Aboriginal and Torres Strait Islander People: A Scoping Review
by: Desalegn Markos Shifti, et al.
Published: (2025)
by: Desalegn Markos Shifti, et al.
Published: (2025)
Evidence of Eczematous Skin Characteristics in Mild Allergic Asthma
by: Anchalee Senavonge, et al.
Published: (2025)
by: Anchalee Senavonge, et al.
Published: (2025)
Similar Items
-
Sputum Eosinophil and Macrophage Changes After Aspirin Challenge in Patients With Nonsteroidal Anti‐Inflammatory Drug–Exacerbated Respiratory Disease
by: Gabriela Trąd‐Wójcik, et al.
Published: (2025) -
Unique effect of aspirin on local 15‐oxo‐eicosatetraenoic acid synthesis in asthma patients with aspirin hypersensitivity
by: Piotr Szatkowski, et al.
Published: (2024) -
Effect of Aspirin Challenge on Innate Lymphoid Cells in Asthma Patients With Aspirin Hypersensitivity
by: Radosław Kacorzyk, et al.
Published: (2025) -
Omics in Nonsteroidal Anti‐Inflammatory Drugs‐Exacerbated Respiratory Disease: Current Evidence From the Upper and Lower Airways
by: Aleksandr iAkushev, et al.
Published: (2025) -
Systemic N‐Acylethanolamines and Other Lipid Mediators Are Associated With NSAID ‐Exacerbated Respiratory Disease
by: Viljami E. Salmi, et al.
Published: (2025)